Today, we’re thrilled to celebrate a major milestone at EyeYon Medical: the 400th commercial implantation of EndoArt® since its launch in September 2023! This achievement marks a transformative moment in corneal care, bringing hope and restored vision to patients worldwide suffering from chronic corneal edema.
From the very first procedure, EndoArt® has redefined what’s possible in ophthalmology as the world’s first synthetic endothelial implant. In just under 18 months, we’ve partnered with visionary surgeons and healthcare providers to make this minimally invasive solution a reality for hundreds, reducing reliance on donor tissue and tackling the global shortage head-on.
A heartfelt thank you to our incredible team, our clinical partners, and the patients who inspire us every day. This is just the beginning—here’s to pushing boundaries, advancing eye care, and making a lasting impact together!
Read More at out Linkdin page
